Crowdonomics
Kermode Biotechnologies Inc.

Reg CF · SAFE · Sep 2025

ClosedReg CFSAFE
via WeFunder · last checked Aug 17, 2026
Raised
$0 / $1.2M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$0
−$304K
FY2023
$0
−$275K
FY2024
RevenueNet income
Metric
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$303,505
-$274,822
Taxes paid
$0
$0
Balance sheet
Cash
$13,526
$4,054
Accounts receivable
$0
$0
Total assets
$500,611
$325,789
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
7

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$50,000
Max$1,235,000
Min investment—
OpenedSep 23, 2025
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active219

Links & provenance

Source: SEC EDGAR
0001863649-25-000003
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.